(Q44592956)

4 December 2017

Levels of Lipids, Lipoproteins, and Apolipoproteins in a Defined Population (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)62470-7

15 November 2022

0 references

B. A. Kottke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1749288

15 November 2022

P. P. Moll

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1749288

15 November 2022

V. V. Michels

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1749288

15 November 2022

W. H. Weidman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1749288

15 November 2022

language of work or name

English

0 references

publication date

1 December 1991

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S0025619612624707?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)62470-7

https://api.elsevier.com/content/article/PII:S0025619612624707?httpAccept=text/plain

15 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)62470-7

15 November 2022

1 reference

4 December 2017

66

1 reference

4 December 2017

12

1 reference

4 December 2017

1198-1208

1 reference

Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

Apolipoproteins and coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

Apoproteins B and A-I and coronary artery disease in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

An improved colour reagent for the determination of blood glucose by the oxidase system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

A rapid apolipoprotein E radioimmunoassay using solid-phase staphylococcus protein. Use of pooled plasma as a secondary standard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

The effects of generation and gender on the joint distributions of lipid and apolipoprotein phenotypes in the population at large

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

Apolipoproteins AI, AII and B in young adults: associations with CHD risk factors. The Beaver County experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

Relationship between apolipoproteins and chemical components of lipoproteins in survivors of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

Lipids, lipoproteins and apolipoproteins in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

Quantitation of apolipoprotein A-I of human plasma high density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

Apolipoprotein A-I, A-II and C-II in black and white residents of Evans County

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

The relation between ponderosity and coronary risk factors in children and their relatives. The Muscatine Ponderosity Family Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. The Lipid Research Clinics Program Epidemiology Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962470-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Genetic determination of plasma apolipoprotein AI in a population-based sample

21

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)62470-7

15 November 2022

Identifiers

1 reference

4 December 2017

1 reference